This is a $5,599.68 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The contract has a firm fixed price and a period of performance through July 24, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,563.97 firm fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order worth $19,267.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp under an Indefinite Delivery Contract for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The order has a firm fixed price and an ultimate completion date of September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there are no set-aside designations indicated. This order is part of a larger $999,999,999 Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for 4563680248 - OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, with a completion date of February 16, 2024 and a potential value of $1,786.22. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a...
This is a $2,269.38 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of August 12, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to various government agencies, including the military, through multiple Indefinite Delivery Contracts (IDCs). One notable IDC is with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The contract has a ceiling value of $4,888.26 and is a firm fixed price contract. The ultimate completion date is August 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product. The award, valued at $27,412.22, has a firm-fixed-price contract type and an ultimate completion date of September 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a potential value of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,031.90 contract is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a specialty pharmaceutical product, with a period of performance through April 4, 2024.
Amerisourcebergen Drug Corp is the prime contractor on an...
This is a $17,887.98 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, with a period of performance ending on May 14, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 through December 2025. The IDC serves as the...
The Defense Logistics Agency (DLA) awarded a $1,483.19 Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...